White-Label Pharmacy: How It Works, 503A vs 503B, and What It Costs

A white-label pharmacy, in telehealth, is a licensed pharmacy that fills and ships your brand's prescriptions while the patient experience carries your name. The pharmacy itself cannot be white-labeled: it dispenses under its own state license and legal name. What you brand is the clinic, the platform and the fulfillment experience around the prescription.

Is a white label pharmacy legit?

It is legitimate when three things are true. The dispensing pharmacy is licensed in the patient's state, or registered with FDA as a 503B outsourcing facility and licensed where required. Every order is filled on a valid, patient-specific prescription written by a clinician licensed in that state after a real evaluation. And the pharmacy's name appears on the label and the paperwork, so the patient and the regulator can see who dispensed the drug.

It stops being legitimate when a vendor hides the dispensing pharmacy, ships without a prescription, lets the brand rather than the clinician decide who gets medication, or markets compounded drugs as FDA-approved. FDA has written to telehealth companies about promoting compounded drugs as safe, effective or approved, and the Federal Trade Commission treats health claims without substantiation as deceptive. So the question is never whether the phrase is allowed. It is whether the structure behind it holds up.

White-label pharmacy at a glance

How a white-label pharmacy works in a telehealth program

The sequence is the same on any platform that is structured correctly. What differs between vendors is how much of it is already built and who is paid at each step.

1. 1The patient finds your brand, completes a state-aware intake on your domain and pays your program fee.
2. 2An independently licensed clinician in the patient's state reviews the intake, holds a visit where the state requires one, and decides whether to prescribe. Your brand does not make that decision.
3. 3If a prescription is written, it is sent electronically to a pharmacy that is licensed for that patient's state and able to supply that product.
4. 4The pharmacy compounds or dispenses the medication, labels it in its own name with the prescriber and patient identified, and ships it directly to the patient.
5. 5Order status, refill reminders and messages reach the patient through your branded portal, so the experience stays yours even though the label is the pharmacy's.
6. 6Renewals go back through the clinician, and a network with more than one pharmacy can route around a facility that loses a state permit or runs short of product.

On a platform with a pre-integrated network, steps three through six are already connected to the intake, the EMR and the e-prescribing system. Without one, each pharmacy relationship is a separate contract, a separate integration and a separate credentialing file. How to choose and verify a telehealth compounding pharmacy covers that work in detail.

503A vs 503B: which pharmacy fills your prescriptions?

Section 503A of the Federal Food, Drug, and Cosmetic Act covers compounding by a licensed pharmacist in a state-licensed pharmacy, or by a physician, for an identified patient on a valid prescription. When the conditions are met, the compounded drug is exempt from the new drug approval, labeling and current good manufacturing practice requirements that apply to manufacturers. A 503A pharmacy may compound from a bulk drug substance only if it has a USP or NF monograph, is a component of an FDA-approved drug, or appears on FDA's 503A bulks list, and it may not compound what is essentially a copy of a commercially available drug except in the circumstances FDA describes.

Section 503B covers outsourcing facilities, which register with FDA, pay a fee, report the products they make, report adverse events and are inspected against current good manufacturing practice. An outsourcing facility may compound without patient-specific prescriptions, which is why clinics that keep medication in stock for in-office use buy from 503B facilities. Its bulk substances come from the 503B bulks list or from FDA's shortage list.

For a telehealth brand shipping to patients at home, the fill is almost always patient-specific, so a 503A pharmacy is the usual partner, with a 503B facility added when a program needs office stock or a product only a 503B facility can supply. In either case the product is a compounded drug, not an FDA-approved one, and your marketing has to say so where it matters. The 503A versus 503B comparison goes line by line through the two frameworks.

What does a white-label pharmacy cost?

No federal source publishes a price for compounded drugs, so any vendor quoting a market average is quoting its own list. The cost has five parts, and only one of them is the drug.

MDLaunchr's model puts pharmacy fulfillment inside the flat monthly platform fee: the Launch plan, at $297 a month for one program, includes pharmacy fulfillment, and the Growth plan, at $597 a month for up to four programs, adds multi-pharmacy routing and failover. There is no medication markup, no per-patient fee and no revenue share, and patient payments settle to your own merchant account. The pricing page lists every plan and what it includes.

What you can and cannot put your name on

• You can brand the clinic, the domain, the intake, the patient portal, the emails and texts, the program design and the price the patient pays.
• You can choose which programs to offer and which states to open in, within what the clinicians and pharmacies in the network are licensed to do.
• You cannot put your name on the prescription label, the pharmacy license or the clinician's license, and you cannot direct the clinician's decision to prescribe.
• You cannot describe a compounded drug as FDA-approved, or imply that a pharmacy's FDA registration is an approval of its products.
• You cannot sell prescription medication without a prescription, or let a questionnaire stand in for an evaluation in a state that requires more.

What changed recently

FDA has stepped up attention on compounded GLP-1 medications and on the telehealth companies that market them. It has warned telehealth companies against illegal marketing of compounded GLP-1s, published guidance for telehealth companies on what to know when promoting compounded drugs, and proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list. For a white-label brand the practical effect is that the pharmacy's compliance history and the wording of your own marketing now carry as much weight as the price per fill.

How to verify a white-label pharmacy before you launch

1. 1Get the legal name, address and state license number of every facility that will fill for you, not the name of the network or the platform.
2. 2Check each facility's license with the board of pharmacy in its home state and confirm nonresident permits for every state you plan to ship to.
3. 3For a 503B facility, confirm it appears on FDA's list of registered outsourcing facilities and read its inspection history.
4. 4Search FDA's compounding inspections, recalls and warning letters for the facility and for its owners.
5. 5Confirm in writing which products it is authorized to compound for your programs and from which bulk substances.
6. 6Put price per fill, shipping, turnaround, failure handling and what happens if the pharmacy loses a permit into the contract, and recredential on a schedule.

Pharmacy network credentialing for telehealth walks through each of those checks with the questions to ask.

How MDLaunchr's pharmacy network works

MDLaunchr is a white-label telehealth platform, not a pharmacy. Its provider and pharmacy network connects your brand to vetted, licensed, independent compounding partners that are already integrated with the platform's intake, EMR and e-prescribing, so there are no pharmacy contracts for you to negotiate. Prescriptions are filled and shipped direct to the patient under your brand's experience and the pharmacy's label, with multi-pharmacy routing on the Growth plan so a single facility is never a single point of failure. Every prescribing decision stays with the independently licensed clinician, and every pharmacy dispenses under its own license and name.

Disclaimer

This article is general business and regulatory information, not legal, medical or pharmacy advice. Compounding, prescribing and advertising rules differ by state and change over time; confirm current requirements with a licensed attorney and the relevant boards before launching a program.